Skip to main content

Table 4 Pathologic complete response and radiologic response rate according to ER/PR/c-erbB2

From: Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

  

No. of Pts

pCR (N = 11)

p-value

Radiologic Response (RR %)

p-value

Variables

  

No. of Pts (%)

 

No. of Pts (%)

 

ER

Positive

64

1 (1.6)

0.023

41 (64.1)

0.257

 

Negative

81

10 (12.3)

 

59 (72.8)

 

PR

Positive

44

1 (2.3)

0.173

28 (63.6)

0.360

 

Negative

101

10 (9.9)

 

72 (71.3)

 

c-erbB2

0/+/++

107

9 (8.4)

0.728

76 (71.0)

0.368

 

+++

38

2 (5.3)

 

24 (63.2)

Â